Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

✍ Scribed by M.T. Voso; L. Fianchi; M. Criscuolo; M. Greco; F. D’Alo; S. Hohaus; L. Pagano; G. Leone

• Book ID: 113773543
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 205 KB
• Volume: 36
• Category: Article
• ISSN: 0145-2126
• DOI: 10.1016/j.leukres.2011.08.010